Sign In
Buy ATNX
$0.203
+0 (+0%)
At Close: Aug 23, 2023
BUFFALO, N.Y., July 06, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for
SHAREHOLDER ALERT: Robbins LLP is Investigating Athenex, Inc. (ATNX) for Shareholders
02:57pm, Monday, 07'th Jun 2021
SAN DIEGO & BUFFALO, N.Y.--(BUSINESS WIRE)---- $ATNX #ATNX--Shareholder rights law firm Robbins LLP is investigating Athenex, Inc. (NASDAQ: ATNX) to determine whether certain Athenex officers and dire
Athenex Presents Data on Oral Docetaxel and Oral Paclitaxel at ASCO2021 Virtual Scientific Program
09:05am, Friday, 04'th Jun 2021
BUFFALO, N.Y., June 04, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for
European Commission Decision Anticipated by July 2021 European Commission Decision Anticipated by July 2021
BUFFALO, N.Y., May 17, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for t
Athenex, Inc. (ATNX) CEO Johnson Lau on Q1 2021 Results - Earnings Call Transcript
02:13am, Saturday, 08'th May 2021
Athenex, Inc. (ATNX) CEO Johnson Lau on Q1 2021 Results - Earnings Call Transcript
ATNX Stock: 13.19% Decrease (From $4.55 To $3.95) Intraday Explanation
02:51pm, Thursday, 06'th May 2021
The stock price of Athenex Inc (NASDAQ: ATNX) decreased 13.19% (from $4.55 to a day low of $3.95) during intraday trading. This is why it happened.
Athenex: Q1 Earnings Insights
07:36am, Thursday, 06'th May 2021
Shares of Athenex (NASDAQ:ATNX) moved higher by 2.2% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 12.50% over the past year to ($0.27), w
Why Athenex Stock Skyrocketed Today
05:12pm, Wednesday, 05'th May 2021
A blockbuster acquisition could help the biotech "convert cancer into a chronic disease."
ATNX Stock: From $3.71 To $4.97 (33.96% Increase) Pre-Market Explanation
07:50am, Wednesday, 05'th May 2021
The stock price of Athenex Inc (NASDAQ: ATNX) increased from $3.71 to $4.97 pre-market. This is why it happened.
Athenex Shares Gain After Acquiring Kuur Therapeutics For $70M Cash, $115M Milestone Payments
07:00am, Wednesday, 05'th May 2021
Athenex Inc (NASDAQ: ATNX) shares have risen during premarket trading in reaction to acquiring Kuur Therapeutics Inc, a portfolio company of IP Group plc, for $70 million upfront. Additionally, K
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform
05:04pm, Tuesday, 04'th May 2021
BUFFALO, N.Y., May 04, 2021 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for
New York, New York--(Newsfile Corp. - May 3, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Athe
Los Angeles, California--(Newsfile Corp. - May 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Athenex, Inc. ("Athene
New York, New York--(Newsfile Corp. - May 2, 2021) - WHY:. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 201
